Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
36.27
+0.81 (+2.28%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
28
29
Next >
Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound
↗
May 23, 2024
Discover three top Nasdaq stocks to buy. Learn about these investment opportunities and why they’re worth your attention.
Via
InvestorPlace
Is It Too Late to Buy Viking Therapeutics Stock?
↗
May 22, 2024
This rising star probably won't burn out soon.
Via
The Motley Fool
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
↗
May 21, 2024
Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and call it a day."
Via
Benzinga
Topics
ETFs
3 Growth Stocks That Could Be Millionaire-Makers: May Edition
↗
May 21, 2024
Investors wanting to get rich should consider a long-term holding in these stocks, each of which has risen exponentially in the last year.
Via
InvestorPlace
Wall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for May 2024
↗
May 20, 2024
Consider following the recommendations of analysts and buy these small but mighty companies whose stocks are rising.
Via
InvestorPlace
Smart Money Is Betting Big In VKTX Options
↗
May 17, 2024
Via
Benzinga
Is Viking Therapeutics Stock a Buy?
↗
May 17, 2024
The stock could have room to soar higher if VK2735 obtains approval from regulators.
Via
The Motley Fool
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
↗
May 15, 2024
Via
Benzinga
3 Monster Stocks in the Making You Can Buy Right Now
↗
May 18, 2024
These stocks might not be small for too much longer.
Via
The Motley Fool
Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?
↗
May 17, 2024
Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.
Via
InvestorPlace
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
↗
May 17, 2024
The Benzinga Stock Whisper highlights five stocks weekly that are seeing increased interest from readers.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
May 17, 2024
Via
Benzinga
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
↗
May 17, 2024
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.
Via
InvestorPlace
How Is The Market Feeling About Viking Therapeutics?
↗
May 14, 2024
Via
Benzinga
Viking Therapeutics's Options Frenzy: What You Need to Know
↗
May 08, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
↗
May 01, 2024
Via
Benzinga
Tiny but Mighty: 3 Small-Cap Stocks Crushing the Russell 2000
↗
May 16, 2024
Top small-cap stocks to buy Viking Therapeutics, Celsius and Hippo make waves in the weight loss, energy drink, and insurance tech sectors.
Via
InvestorPlace
Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
↗
May 14, 2024
These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet.
Via
InvestorPlace
How Viking Therapeutics Stock Could 30x
↗
May 13, 2024
This mid-cap biopharma may one day be a titan of the industry.
Via
The Motley Fool
Is Viking Therapeutics the Best Biotech Stock for You?
↗
May 13, 2024
With good mid-stage results and plenty of cash, Viking could be a winner.
Via
The Motley Fool
The 3 Best Russell 2000 Stocks to Buy in May 2024
↗
May 10, 2024
If you are looking for investments that will deliver high returns, these are the best Russell 2000 stocks to buy for your portfolio.
Via
InvestorPlace
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
↗
May 09, 2024
The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving.
Via
InvestorPlace
Check Out What Whales Are Doing With VKTX
↗
April 30, 2024
Via
Benzinga
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
↗
May 07, 2024
Investors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy.
Via
InvestorPlace
Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
May 06, 2024
Eli Lilly stock continues to move higher after the company reported continuing momentum for its flagship GLP-1 weight loss drugs
Via
MarketBeat
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
↗
May 04, 2024
The anti-obesity medication stock is way up, and there could be more fuel in the tank.
Via
The Motley Fool
What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks
↗
May 02, 2024
Data indicates that many more Americans have become aware of the dangers of obesity. Here are the best weight loss stocks to buy now.
Via
InvestorPlace
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
↗
May 01, 2024
A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
↗
April 30, 2024
Via
Benzinga
Is Viking Therapeutics Incredibly Undervalued?
↗
April 28, 2024
The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.
Via
The Motley Fool
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
28
29
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.